Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.
Fox LC, Cummins KD, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A. Fox LC, et al. Among authors: yeung d. Blood Adv. 2017 May 15;1(13):802-811. doi: 10.1182/bloodadvances.2016003889. eCollection 2017 May 23. Blood Adv. 2017. PMID: 29296724 Free PMC article.
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.
Minson AG, Cummins K, Fox L, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A. Minson AG, et al. Among authors: yeung d. Blood Adv. 2019 Apr 9;3(7):1084-1091. doi: 10.1182/bloodadvances.2018028035. Blood Adv. 2019. PMID: 30944100 Free PMC article.
An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.
Greenwood M, Trahair T, Sutton R, Osborn M, Kwan J, Mapp S, Howman R, Anazodo A, Wylie B, D'Rozario J, Hertzberg M, Irving I, Yeung D, Coyle L, Jager A, Engeler D, Venn N, Frampton C, Wei AH, Bradstock K, Dalla-Pozza L. Greenwood M, et al. Among authors: d rozario j, yeung d. Blood Adv. 2021 Dec 28;5(24):5574-5583. doi: 10.1182/bloodadvances.2021005576. Blood Adv. 2021. PMID: 34662896 Free PMC article.
ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management.
Fleming S, Scott AP, Coutsouvelis J, Fraser C, Bajel A, Nelson A, Conyers R, McEwan A, Yeung D, Campion V, Teague L, McGuire M, Morris E, Gabriel M, Wayte R, Douglas G, Chien N, Hamad N. Fleming S, et al. Among authors: yeung d. Intern Med J. 2024 Sep;54(9):1548-1556. doi: 10.1111/imj.16453. Epub 2024 Jul 30. Intern Med J. 2024. PMID: 39076028 Review.
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Kimura S, Montefiori L, Iacobucci I, Zhao Y, Gao Q, Paietta EM, Haferlach C, Laird AD, Mead PE, Gu Z, Stock W, Litzow M, Rowe JM, Luger SM, Hunger SP, Ryland GL, Schmidt B, Ekert PG, Oshlack A, Grimmond SM, Rehn J, Breen J, Yeung D, White DL, Aldoss I, Jabbour EJ, Pui CH, Meggendorfer M, Walter W, Kern W, Haferlach T, Brady S, Zhang J, Roberts KG, Blombery P, Mullighan CG. Kimura S, et al. Among authors: yeung d. Blood. 2022 Jun 16;139(24):3519-3531. doi: 10.1182/blood.2022015444. Blood. 2022. PMID: 35192684 Free PMC article.
713 results